Efficacy of Lactococcus lactis strain plasma (LC-Plasma) in easing symptoms in patients with mild COVID-19: protocol for an exploratory, multicentre, double-blinded, randomised controlled trial (PLATEAU study)

INTRODUCTION: The COVID-19 pandemic has been a major concern worldwide; however, easily accessible treatment options for patients with mild COVID-19 remain limited. Since the oral intake of Lactococcus lactis strain plasma (LC-Plasma) enhances both the innate and acquired immune systems through the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kazuko, Hosogaya, Naoki, Inoue, Tsuyoshi, Jounai, Kenta, Tsuji, Ryohei, Fujiwara, Daisuke, Yanagihara, Katsunori, Izumikawa, Koichi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475960/
https://www.ncbi.nlm.nih.gov/pubmed/36104128
http://dx.doi.org/10.1136/bmjopen-2022-061172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475960/
https://www.ncbi.nlm.nih.gov/pubmed/36104128
http://dx.doi.org/10.1136/bmjopen-2022-061172

Ejemplares similares